Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AR underexpression + IL1R1 underexpression + CCND1 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

AR elevation (1)

AR positive + HER-2 amplification (1)

PD-L1 overexpression + RET-KIF5B fusion + TP53 mutation + AR mutation + RET rearrangement (1)

ALK fusion + MYC amplification + CCND1 deletion + FGFR3 deletion (1)

ALK positive + MYC amplification + CCND1 deletion (1)

CCND1 mutation + HR positive (1)

EGFR exon 19 deletion + CCND1 overexpression (1)

EGFR mutation + CCND1 expression + CDKN2A deletion (1)

ER L536H + ER D538G + CCND1 amplification (1)

ER positive + ESR1 mutation + CCND1 amplification (1)

HR positive + CCND1 amplification (1)

AR elevation (1)

AR positive + HER-2 amplification (1)

PD-L1 overexpression + RET-KIF5B fusion + TP53 mutation + AR mutation + RET rearrangement (1)

ALK fusion + MYC amplification + CCND1 deletion + FGFR3 deletion (1)

ALK positive + MYC amplification + CCND1 deletion (1)

CCND1 mutation + HR positive (1)

EGFR exon 19 deletion + CCND1 overexpression (1)

EGFR mutation + CCND1 expression + CDKN2A deletion (1)

ER L536H + ER D538G + CCND1 amplification (1)

ER positive + ESR1 mutation + CCND1 amplification (1)

HR positive + CCND1 amplification (1)

›

AR underexpression + IL1R1 underexpression + CCND1 overexpression

Acute Myelogenous Leukemia

venetoclax + ABBV-744

Sensitive: D – Preclinical

venetoclax + ABBV-744

venetoclax + ABBV-744

Sensitive: D – Preclinical

venetoclax + ABBV-744